Sonal Sonu/LinkedIn
Feb 14, 2026, 17:18
Sonal Sonu: A Compatible Crossmatch Does Not Guarantee Transfusion Safety
Sonal Sonu, Transfusion Medicine Specialist, posted on LinkedIn:
“A compatible crossmatch confirms serological compatibility at the time of testing – not absolute transfusion safety.
Evanescent alloantibodies and anamnestic immune responses can still result in delayed hemolytic transfusion reactions.
Safe transfusion is not just about reports.
It requires patient history, clinical context, and vigilance.
Transfusion medicine is clinical judgment – not a checkbox.”
Stay updated with Hemostasis Today.
-
Oct 16, 2026, 13:59Aya Akmal Amin: Antiphospholipid Syndrome Management and Risk Stratification
-
Oct 16, 2026, 13:10Emanuel Sueldo: CAHT 2026 Celebrates Scientific Progress and Team Achievements
-
Oct 16, 2026, 13:05Maha Othman: Queen’s Health Sciences Advances CAT Risk Models and Pediatric ISTH-BAT Cut-Offs
-
Oct 16, 2026, 13:03Thrombosis Awareness Must Lead to Timely Action – Roche
-
Oct 16, 2026, 12:49Wolfgang Miesbach: 5-Year CBDR Data Confirms Emicizumab Safety and Efficacy in Hemophilia A
-
Oct 16, 2026, 12:40Edward Lee Carter: How Factor XI Inhibition Could Transform Anticoagulation Therapy
-
Oct 16, 2026, 12:40Marc Carrier: Looking Ahead to ISTH 2027 in Vancouver
-
Oct 16, 2026, 12:30Bob Lempke: How One Blood Donation Can Save Up to Three Lives
-
Oct 16, 2026, 12:30Why VWF Therapies Belong on the EU Critical Medicines List – EHC